Posizioni attive di Charlie Qi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TRANSCENTA HOLDING LIMITED | Direttore Tecnico/Scientifico/R&S | 01/08/2020 | - |
| Roche Global Product Development Center | Corporate Officer/Principal | 01/08/2017 | - |
Storia della carriera di Charlie Qi
Precedenti posizioni note di Charlie Qi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/05/2012 | 01/08/2017 |
Statistiche
Distribuzione geografica
| Cina | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRANSCENTA HOLDING LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
| Roche Global Product Development Center | |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Charlie Qi
- Esperienza
